{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":37,"n_cols":5,"rows_kept":37,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[11,2,11,3],[12,2,12,3],[15,2,15,3],[21,2,21,3],[21,4,21,5],[22,2,22,3],[22,4,22,5],[23,2,23,3],[24,2,24,3],[25,2,25,3],[26,2,26,3],[28,2,28,3],[30,2,30,3],[31,2,31,3],[35,2,35,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910779857103321"]
[null,null,"Autore",null,"Mulliken John B"]
[null,null,"Titolo",null,"Mulliken and Young's vascular anomalies : hemangiomas and malformations / / editors, John B. Mulliken, Patricia E. Burrows, Steven J. Fishman"]
[null,null,"Pubbl/distr/stampa",null,"Oxford : , : Oxford University Press, , 2013"]
[null,null,"ISBN",null,"0-19-935714-5"]
[{"$nulls":4},"0-19-972254-4"]
[null,null,"Edizione",null,"[Second edition.]"]
[null,null,"Descrizione fisica",null,"1 online resource (1139 pages)"]
[null,null,"Disciplina",null,"616.8/1"]
[null,null,"Soggetti",null,"Hemangiomas"]
[{"$nulls":4},"Abnormalities, Human"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"Cover; Contents; Contributors; Foreword; Preface; Preface from Mulliken and Young's Vascular Birthmarks (1st Edition); Acknowledgments; Part One: Background; 1. Vascular Birthmarks in Folklore, History, Art, and Literature; 2. Classification of Vascular Anomalies; Part Two: Infantile Hemangiomas and Other Vascular Tumors; 3. Pathogenesis of Infantile Hemangioma; 4. Diagnosis and Natural History of Hemangiomas; 5. Radiological Imaging of Hemangiomas and Related Vascular Tumors; 6. Treatment of Cutaneous Hemangiomas; 7. Treatment of Visceral Vascular Tumors"]
[{"$nulls":4},"8. Vascular Tumors and Tumor-Like Lesions; Part Three: Vascular Malformations; 9. Molecular Genetics of Vascular Malformations; 10. Clinical Assessment of Vascular Malformations; 11. Radiological Imaging of Vascular Malformations; 12. Histopathology of Vascular Malformations; 13. Capillary Malformations, Hyperkeratotic Stains, Telangiectasias, and Miscellaneous Vascular Blots; 14. Slow-Flow Vascular Malformations; 15. Fast-Flow Vascular Malformations; 16. Vascular Malformations with Overgrowth; Part Four: Management of Vascular Malformations; 17. Coagulopathy and Vascular Malformations"]
[{"$nulls":4},"18. Laser Therapy of Vascular Malformations; 19. Percutaneous Treatment of Slow-Flow Vascular Malformations; 20. Endovascular Treatment of Fast-Flow Vascular Anomalies; 21. Vascular Malformations of the Central Nervous System; 22. Hereditary Hemorrhagic Telangiectasia; 23. Vascular Malformations of the Head and Neck; 24. Vascular Malformations of the Extremities; 25. Truncal, "]
[{"$nulls":4},"Visceral, and Genital Vascular Malformations; 26. Anomalies of the Aorta and Major Branches; 27. Combined Slow-Flow Vascular Malformation of the Lower Limb: Klippel- Trenaunay Syndrome"]
[{"$nulls":4},"28. Orthopaedic Issues in Vascular Malformations29. Primary Lymphedema; 30. The Emotional Impact of a Vascular Facial Birthmark; Glossary; Index"]
[null,null,null,"Sommario/riassunto","The field of vascular anomalies has grown rapidly in last 25 years. Molecular genetics has led to discovery of genes that cause vascular anomalies. Interventional radiology has become a major contributor to accurate diagnosis and management of previously untreatable disorders. New pharmacologic therapies are under investigation and surgical protocols have been established."]
[null,"2.","Record Nr.",null,"UNINA9910786108003321"]
[null,null,"Titolo",null,"Vascular considerations in glaucoma [[electronic resource] ] : current perspectives / / edited by Alon Harris"]
[null,null,"Pubbl/distr/stampa",null,"Amsterdam, Netherlands, : Kugler, 2012"]
[null,null,"ISBN",null,"90-6299-859-3"]
[null,null,"Descrizione fisica",null,"1 online resource (126 p.)"]
[null,null,"Disciplina",null,"617.7"]
[{"$nulls":4},"617.74100223"]
[null,null,"Soggetti",null,"Glaucoma"]
[{"$nulls":4},"Retina - Blood-vessels"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references."]
[null,null,"Nota di contenuto",null,"ABOUT THE AUTHORS; 1. BACKGROUND - THE EMERGENCE OF THEVASCULAR DYSREGULATION THEORY; 2. CLINICAL MEASUREMENT OF OCULAR BLOODFLOW; 3. AUTOREGULATION; 4. VASCULAR RISK FACTORS; 5. DIURNAL VARIATIONS OF INTRAOCULARPRESSURE, BLOOD PRESSURE AND PERFUSIONPRESSURE; 6 THE RELATIONSHIP BETWEEN BLOOD FLOWAND STRUCTURE; 7. OCULAR BLOOD FLOW AND VISUAL FUNCTION; 8. CEREBROSPINAL FLUID PRESSURE ANDGLAUCOMA; 9. TOPICAL MEDICATIONS AND OCULAR BLOODFLOW"]
[null,null,null,"Sommario/riassunto","PrefaceOpen angle glaucoma (OAG) is one of the leading causes of impaired vision worldwide. The pathogenesis of glaucomatous optic neuropathy remains poorly understood, and several pathogenic mechanisms are proposed to coexist. As the world population ages, OAG will become more prevalent and advances in the diagnosis and treatment of glaucomatous optic neuropathy are important to protect and improve the quality of life of our aging population.Treatment of OAG has been directed at lowering intraocular pressure (IOP) which is the only current therapeutic strategy available to patients with glauc"]